Home › Funds › BARROW HANLEY MEWHINNEY & STRAUSS LLC › HUM

BARROW HANLEY MEWHINNEY & STRAUSS LLC position in HUM

HUMANA INC · Health Care

BARROW HANLEY MEWHINNEY & STRAUSS LLC reported holding 766,535 shares of HUM (HUMANA INC) in its Q3 2026 13F filing — a position valued at US$292.5M, representing 0.93% of its reported portfolio and ranking #45 among its reported holdings. BARROW HANLEY MEWHINNEY & STRAUSS LLC has disclosed HUM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)766.53K sh
Reported value held$292.49M
Portfolio Weight0.93%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How BARROW HANLEY MEWHINNEY & STRAUSS LLC's HUM position evolved

BARROW HANLEY MEWHINNEY & STRAUSS LLC first disclosed a stake in HUM in Q3 2023 at 136,881 shares (US$66.6M). The position peaked in Q2 2026 at 792,814 shares, worth US$314.9M. Across 13 filings, BARROW HANLEY MEWHINNEY & STRAUSS LLC increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 766,535 shares valued at US$292.5M — a reduction of -26,279 shares quarter over quarter.. Notable position changes include a 370% increase in Q4 2023 (shares fell 24% over the following quarter), a 89% trim in Q4 2024 (shares rose 5% over the following quarter), a 436% increase in Q4 2025 (shares fell 32% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 136.88K $66.60M New
Q4 2023 643.87K $294.77M Add
Q1 2024 884.06K $306.52M Add
Q2 2024 680.73K $254.36M Reduce
Q3 2024 637.84K $202.03M Reduce
Q4 2024 71.34K $18.10M Reduce
Q1 2025 68.78K $18.20M Reduce
Q2 2025 94.42K $23.08M Add
Q3 2025 91.91K $23.91M Reduce
Q4 2025 492.77K $126.21M Add
Q1 2026 543.86K $94.30M Add
Q2 2026 792.81K $314.92M Add
Q3 2026 766.53K $292.49M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HUM and 13F data

HUM (HUMANA INC) is a Health Care company. 30 other funds we track also report a position in HUM — the largest reported positions include Dodge & Cox (US$4.35B), DODGE & COX (US$4.35B), EAGLE CAPITAL MANAGEMENT LLC (US$1.53B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HUM

All HUM fund holders →

FAQ

How long has BARROW HANLEY MEWHINNEY & STRAUSS LLC held HUM?

BARROW HANLEY MEWHINNEY & STRAUSS LLC has disclosed HUM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BARROW HANLEY MEWHINNEY & STRAUSS LLC's current position in HUM?

As of Q3 2026, BARROW HANLEY MEWHINNEY & STRAUSS LLC holds 766.53K shares of HUM (HUMANA INC), valued at $292.49M, representing 0.93% of its reported portfolio and ranking #45.

Has BARROW HANLEY MEWHINNEY & STRAUSS LLC been buying or selling HUM?

In the latest 13F filing (Q3 2026), BARROW HANLEY MEWHINNEY & STRAUSS LLC reduced its position in HUM. The position peaked in Q2 2026 at 792.81K shares.

Which other funds hold HUM?

Other major institutional holders of HUM include Dodge & Cox, DODGE & COX, EAGLE CAPITAL MANAGEMENT LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.